Try our beta test site
2138 studies found for:    cancer | Interventional Studies | antibody therapy
Show Display Options
Rank Status Study
1 Recruiting Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
Conditions: HER2/Neu Positive;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Biological: HER-2/neu Intracellular Domain Protein;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Placebo;   Biological: Polysaccharide-K;   Biological: Trastuzumab
2 Active, not recruiting Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy
Condition: Lung Cancer
Interventions: Other: high performance liquid chromatography;   Other: pharmacological study;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: radiation therapy;   Radiation: yttrium Y 90 anti-CEA monoclonal antibody cT84.66
3 Recruiting Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
Conditions: Advanced Cancer;   Breast Cancer;   Gastric Cancer;   Esophageal Cancer;   Colorectal Cancer
Interventions: Drug: Pembrolizumab;   Drug: Trastuzumab;   Drug: ado-trastuzumab emtansine;   Drug: Cetuximab
4 Recruiting Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Neuroblastoma;   Sarcoma
Intervention: Radiation: iodine I 131 monoclonal antibody 8H9
5 Withdrawn Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: monoclonal antibody anti-anb3 integrin;   Procedure: anti-cytokine therapy;   Procedure: antiangiogenesis therapy;   Procedure: antibody therapy;   Procedure: biological response modifier therapy;   Procedure: growth factor antagonist therapy;   Procedure: monoclonal antibody therapy
6 Completed Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: monoclonal antibody huJ591
7 Completed Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: monoclonal antibody muJ591;   Radiation: iodine I 131 monoclonal antibody muJ591
8 Completed Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Biological: etaracizumab
9 Completed Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Other: immunohistochemistry staining method;   Procedure: biopsy;   Procedure: immunoscintigraphy;   Radiation: indium In 111 monoclonal antibody Hu3S193
10 Completed Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Biological: monoclonal antibody Hu3S193
11 Unknown  Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Radiation: indium In 111 monoclonal antibody MN-14;   Radiation: yttrium Y 90 monoclonal antibody MN-14
12 Completed Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: panitumumab
13 Completed Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: paclitaxel
14 Completed Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Procedure: radionuclide imaging;   Radiation: iodine I 131 monoclonal antibody F19
15 Unknown  Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
Condition: Breast Cancer
Intervention: Biological: monoclonal antibody HuHMFG1
16 Unknown  Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Radiation: indium In 111 monoclonal antibody MN-14;   Radiation: yttrium Y 90 monoclonal antibody MN-14
17 Completed Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: indium In 111 monoclonal antibody BrE-3;   Radiation: yttrium Y 90 monoclonal antibody BrE-3
18 Completed Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
Condition: Kidney Cancer
Intervention: Radiation: iodine I 131 chimeric monoclonal antibody G-250
19 Terminated Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Melanoma;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Stage IV Melanoma;   Stage IV Non-small Cell Lung Cancer
Intervention: Biological: ipilimumab
20 Completed Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.